Aristopharma Ltd. has launched Triflo, a FDA approved ICS+LABA+LAMA combination consisting of Fluticasone Furoate, Vilanterol & Umeclidinium as Dry Powder Inhalation Capsule.

“Triflo Arocap”, a once-daily triple combination of ICS/LAMA/LABA consisting of Fluticasone, Umeclidinium & Vilanterol, the first and only once-daily, 3-in-1 treatment option, approved by USFDA to meet your patients’ necessities and conveniences. 

Truly Once-daily 3-in-1 medicine of Triflo Arocap works combinedly to control Asthma, COPD & ACO

Triflo Arocap ensures excellent lung function improvement in both Asthma & COPD patients compared to LAMA/LABA or ICS/ LABA

Triflo Arocap combination is recommended & approved by various guidelines & regulatory agencies e.g., FDA, EMA, GINA, GOLD, BNF, etc.